In AML t(8;21) colony growth of both leukemic and residual normal progenitors is restricted to the CD34+, lineage-negative fraction

Leukemia

Volumn 12, Issue 11, 1998, Pages 1782-1788

  Wittebol, S ^a   Raymakers, R ^a   Van De Locht, L ^a   Mensink, E ^a   De Witte, T ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute myeloid leukemia; AML ETO; CD34; Stem cell; t(8; 21)

Indexed keywords

CD19 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; CLINICAL ARTICLE; COLONY FORMATION; ERYTHROID CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA CELL; PRIORITY JOURNAL; STEM CELL;

EID: 0031756982     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401178     Document Type: Article

References (23)

1. Fialkow PJ, Singer JW, Adamson JW, Vaidya K, Dow LW, Ochs J, Moohr JW. Acute nonlymphocytic leukemia: heterogeneity of stem eel! origin. Blood 1981 57: 1068-1073.
2. Fialkow PJ, Singer JW, Raskind WH, Adamson JW, Jacobson RJ, Bernstein ID, Dow LW, Najfeld V, Veith R. Clonal development stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia. New Engl J Med 1987; 317: 468-473.
3. McCulloch EA. Stem cell renewal and determination during clonal expansion in normal and leukaemic haemopoiesis. Cell Prolif 1993; 26: 399-425.
4. Terpstra W, Prins A, Ploemacher RE, Wognum BW, Wagemaker G, Lowenberg B, Wielenga JJ. Long-term leukemia-initiating capacity of a CD34-subpopulation of acute myeloid leukemia. Blood 1996; 87: 2187-2194.
5. +). Leukemia 1995; 9: 450-457.
6. Maruyama F, Stass SA, Estey EH, Cork A, Hirano M, Ino T, Freireich EJ, Yang P, Chang KS. Detection of AML1/ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogenous leukemia. Leukemia 1994; 8: 40-45.
7. Hagemeijer A, Garson OM, Kondo K. Fourth International Workshop on Chromosomes in Leukemia 1982: Translocation (8;21) (q22;q22) in acute nonlymphocytic leukemia. Cancer Gene Cytogene 1984; 11: 284-287.
8. Miyoshi H, Kozu T, Shimizu K, Enomoto K, Maseki N, Kaneko Y, Kamada N, Ohki M. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTC8 fusion transcript. EMBO J 1993; 12: 2715-2721.
9. Erickson P, Gao J, Chang KS, Look T, Whisenant E, Raimondi S, Lasher R, Trujillo J, Rowley J, Drabkin H. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 1992; 80: 1825-1831.
10. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA 1991; 88: 10431-10434.
11. Downing JR, Head DR, Curcio Brint AM, Hulshof MG, Motroni TA, Raimondi SC, Carroll AJ, Drabkin HA, Willman C, Theil KS et al. An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation. Blood 1993; 81: 2860-2865.
12. van de Locht LT, Smetsers TF, Wittebol S, Raymakers RA, Mensink EJ. Molecular diversity in AML 1/ETO fusion transcripts in patients with t(8;21) positive acute myeloid leukaemia. Leukemia 1994; 8: 1780-1784.
13. Porwit MacDonald A, Janossy G, Ivory K, Swirsky D, Peters R, Wheatley K, Walker H, Turker A, Goldstone AH, Burnett A. Leukemia-associated changes identified by quantitative flow cytometry. IV. CD34 overexpression in acute myelogenous leukemia M2 with t(8;21). Blood 1996; 87: 1162-1169.
14. Hurwitz CA, Raimondi SC, Head D Krance R, Mirro J Jr, Kalwinsky DK, Ayers GD, Behm FG. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children (see comments). Blood 1992; 80: 3182-3188.
15. + malignant myeloblasts has implications for minimal residual disease detection in acute myeloid leukemia. Leukemia 1993; 7: 853-858.
16. Boezeman J, Raymakers R, Vierwinden G, Linssen P. Automatic analysis of growth onset, growth rate and colony size of individual bone marrow progenitors. Cytometry 1993; 28: 305-310.
17. Asou H, Tashiro S, Hamamoto K, Otsuji A, Kita K, Kamada N. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. Blood 1991; 77: 2031-2036.
18. Puissant C, Houdebine LM. An improvement of the single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Biotechniques 1990; 8: 148-149.
19. Bernstein ID, Singer JW, Smith FO, Andrews RG, Flowers DA, Petersens J, Steinmann L, Najfeld V, Savage D, Fruchtman S et al. Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia. Blood 1992; 79: 1811-1816.
20. Coulombel L, Eaves C, Kalousek D Gupta C, Eaves A. Long-term marrow culture of cells from patients with acute myelogenous leu-kemia. Selection in favor of normal phenotypes in some but not all cases. J Clin Invest 1985; 75: 961-969.
21. Iland HJ, Croaker CM, Repka E, Radloff TJ, Vincent PC. Long-term bone marrow culture induces terminal differentiation of human myeloid leukemic cells (see comments). Exp Hematol 1987; 15: 1109-1114.
22. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med 1987; 3: 730-737.
23. Can OI, Murdoch B, Larochelle A, Dick JE. Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells. Blood 1997; 90: 641-650.